Amylyx Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (“Amylyx”) today announced the pricing of an upsized underwritten public offering of 6,693,750 shares of its common stock at a public offering price of $32.00 per share. All of the shares of common stock are being offered by Amylyx. Amylyx has granted the underwriters a 30-day option to purchase up … [Read more…]
